Skip to main navigation Skip to search Skip to main content

Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma.

  • L. Feller*
  • , R. A. Khammissa
  • , N. H. Wood
  • , R. J. Jose
  • , J. Lemmer
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Rapidly progressive facial lymphoedema developing concurrently with, or immediately after rapid enlargment of oral Kaposi sarcoma (KS) in HIV-seropositive highly active antiretroviral treatment (HAART)-naïve subjects, foretokens death. We present here an unusual case of HIV-KS in an 11-year-old HIV-seropositive HAART-naïve boy. Our patient's KS disease had had a fulminant course characterised by rapidly progressing oral HIV-KS, resorption of the mandibular alveolar bone process beneath some of the HIV-KS lesions, and rapidly progressive facial lymphoedema. He died 3 weeks after the onset of facial lymphoedema.

Original languageEnglish
Pages (from-to)14, 16-18
JournalSADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging
Volume65
Issue number1
Publication statusPublished - Feb 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma.'. Together they form a unique fingerprint.

Cite this